Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14NKG | ISIN: US46185L1035 | Ticker-Symbol: N/A
Frankfurt
05.02.24
19:40 Uhr
0,110 Euro
0,000
0,00 %
1-Jahres-Chart  (nicht börsennotiert)
INVITAE CORPORATION Chart 1 Jahr

Aktuelle News zur INVITAE

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiEx-Invitae Spinoff Relaunches as Citizen Health, Picks Up $14.5M in Seed Funding1
29.09.Invitae Aktie: Drastischer Kursverfall trotz Umsatzwachstum548Der Aktienkurs des Biotechnologieunternehmens Invitae ist in den letzten Tagen stark eingebrochen. Am 8. September fiel der Kurs um 25% auf 0,0003 USD, was einen besorgniserregenden Trend fortsetzt....
► Artikel lesen
05.08.Labcorp Finalizes Acquisition of Select Assets of Invitae247Extends Labcorp's leadership in genetic testing solutions for oncology and select rare diseases BURLINGTON, N.C., Aug. 5, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative...
► Artikel lesen
31.07.Invitae Corp - 8-K, Current Report6
29.06.Invitae Corp - 8-K, Current Report15
07.05.Invitae Receives Court Approval for Sale to Labcorp473Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Invitae (OTC:NVTAQ), a leading medical genetics company, announced today that the United States Bankruptcy...
► Artikel lesen
25.04.Labcorp Wins Bid To Acquire Invitae Assets For $239 Mln Plus Non-Cash Considerations473WASHINGTON (dpa-AFX) - Invitae said that Labcorp (LH) has emerged as the successful bidder in the company's auction during its sale process under Section 363 of the U.S. Bankruptcy Code. Labcorp...
► Artikel lesen
25.04.Invitae Corporation: Invitae Enters into Agreement with Labcorp for Sale of Business430- Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals - - $239 Million Cash Bid Includes Acquisition of Substantially All of the Company's...
► Artikel lesen
INVITAE Aktie jetzt für 0€ handeln
06.03.Invitae Corporation: Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Results431SAN FRANCISCO, March 6, 2024 /PRNewswire/ -- Invitae (OTC: NVTA), a leading medical genetics company, today announced estimated unaudited fourth quarter and full year 2023 revenue, gross profit...
► Artikel lesen
07.02.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 07.02.20243.972The following instruments on Boerse Frankfurt do have their last trading day on 07.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 07.02.2024ISIN NameCA48311A2092 KAIZEN...
► Artikel lesen
06.02.XFRA IV8: AUSSETZUNG/SUSPENSION753DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILINVITAE CORP. DL-...
► Artikel lesen
30.01.Invitae Corporation: Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics360SAN FRANCISCO, Jan. 30, 2024 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced a partnership with BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage...
► Artikel lesen
22.01.Natera Acquires Reproductive Health Assets from Invitae244AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced that it has acquired from Invitae (NYSE: NVTA), a leading medical...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten